Innovations in ADC Technologies
Summary: There has been a lot of activity in the ADC market in the past 12-18 months in terms of licensing deals, acquisitions and investments. It’s likely no coincidence that this increased interest coincides with an increase in approvals over the past two years. Hear Mike Riley, Catalent Biologics, Regional President, North America, discuss the drivers behind the recent successes in the clinic, current challenges with development and manufacturing and what the future might hold for the ADC industry.